Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ellagic Acid and Annona Muricata May Modulate the Immune Response to High Risk HPV Infection. A Randomized, Controlled Trial.

NCT02263378 is registered in ClinicalTrials.gov with University of Messina as lead sponsor.

NCT NCT02263378
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02263378 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ellagic Acid and Annona Muricata May Modulate the Immune Response to High Risk HPV Infection. A Randomized, Controlled Trial.
Lead sponsor
University of Messina
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2014
Completion date
March 31, 2016
Enrollment
60 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hpv infection